wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q52579594-A2F71902-B8E9-4745-A984-DE227BAB05BC
Q52579594-A2F71902-B8E9-4745-A984-DE227BAB05BC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52579594-A2F71902-B8E9-4745-A984-DE227BAB05BC
Resistance to Anti-Angiogenic Therapy in Cancer-Alterations to Anti-VEGF Pathway.
P2860
Q52579594-A2F71902-B8E9-4745-A984-DE227BAB05BC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52579594-A2F71902-B8E9-4745-A984-DE227BAB05BC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8181eea0ce59c8e4339e2ddce8a1e96d26a000fe
P2860
Dovitinib (TKI258), a multi-target angiokinase inhibitor, is effective regardless of KRAS or BRAF mutation status in colorectal cancer.